The double agent of nuclear medicine
In nuclear medicine, some molecules don’t just gather intelligence, they also act. A theranostic is a double agent inside the body. It works as radiopharmaceuticals, finding the right “lock” to reach abnormal cells. But it carries a second mission: not only to reveal hidden threats, but also to strike them directly.
The first part of its mission is diagnostic. Guided by its biological GPS, the molecule locates its target, often a tumor, and emits a signal detected by scanners. It undercovers the hidden activity inside the body, creating a precise molecular map that shows exactly where the disease is.
The second part is therapeutic. Once the target is identified, the same molecule delivers a carefully measured dose of radiation, attacking malignant cells while sparing healthy tissue. Acting as a precision-guided missile, it hits the target locally, minimizing collateral damage.
Theranostics illustrate the ultimate potential of nuclear medicine: a single molecule that can both detect and treat diseases. By combining diagnosis and therapy in one mission, they enable personalized, precise medicine that works at the molecular level, offering patients targeted treatment and improved outcomes.
*courtesy of NMEU - Hygieia website
Follow our Series about Nuclear Medicine
What is Nuclear Medicine